Verano Holdings Corp. (CNSX: VRNO)
Health Care · Pharmaceuticals · US
CA$7.44
-0.67% today · -27.1% 1Y
Verano Holdings Corp. (CNSX: VRNO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $381.78M and employs 3,780 people.
Over the last twelve months the share price has lost 27.1%, trading between 5.50 and 13.30.
Tweenvest scores Verano Holdings Corp. across four factors: quality 52/100, value 61/100, growth 25/100. Its strongest factor is value.
VRNO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $381.78M
- Revenue (TTM)
- $835.52M
- P/E
- —
- EPS
- -3.58
- Dividend yield
- —
- Beta (5Y)
- 1.48
- 52-week high
- CA$13.30
- 52-week low
- CA$5.50
- Avg volume (3M)
- —
- Shares outstanding
- 73.22M
- Employees
- 3,780
- Next earnings
- —
About Verano Holdings Corp.
Verano Holdings Corp. functions as a comprehensive, vertically integrated cannabis enterprise operating across numerous states in the United States. The company oversees the entire cannabis lifecycle, from cultivating and processing to wholesale distribution and direct-to-consumer retail sales, within Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It provides a variety of artisanal cannabis products through its proprietary brands, including Encore, Avexia, MUV, and Verano, serving both medical and adult-use markets. By May 10, 2022, Verano's operational footprint included 96 retail dispensaries alongside 13 facilities dedicated to cultivation and processing. The firm's corporate base is located in Chicago, Illinois.
- ISIN
- US92339H2004
- Listed since
- Feb 17, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Foresee Pharmaceuticals Co., Ltd.TPEX: 6576 | $385.29M | NT$78.20 | -1.01% |
| Unichem Laboratories LimitedBSE: 506690 | $385.27M | Rs529.60 | -1.10% |
| KYORIN Pharmaceutical Co., Ltd.TSE: 4569 | $382.76M | ¥1,055.00 | -0.94% |
| Kwality Pharmaceuticals LimitedBSE: 539997 | $381.97M | Rs3,562.70 | -0.27% |
| Shinpoong Pharmaceutical Co.,LtdKOSE: A019170 | $375.67M | ₩9,780.00 | +5.73% |
| Honz Pharmaceutical Co., Ltd.SZSE: 300086 | $373.04M | CN¥5.49 | +2.23% |
| Zhejiang Shengda Bio-Pharm Co., Ltd.SHSE: 603079 | $372.46M | CN¥13.31 | -2.20% |
| Taho Pharmaceuticals Ltd.TPEX: 6467 | $368.78M | NT$225.00 | -2.60% |
Figures last refreshed Sep 14, 2024.